RMD Earnings

Quarterly EPS
$2.12
Q1 2025
$2.35
Q2 2025
$2.49
Q3 2025
$2.59
Q4 2025
$2.38
Q1 2026
$2.69
Q2 2026
$2.74
Q3 2026
$2.65
Q4 2026
Latest Revenue1.5B
Latest Net Income383.4M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q4 2026$2.651.5B383.4M+8.6%+2.3%
Q3 2026$2.741.4B398.7M+10.8%+10.0%
Q2 2026$2.691.4B392.6M+11.0%+14.5%
Q1 2026$2.381.3B348.5M+9.1%+12.3%
Q4 2025$2.591.3B379.7M+10.2%+30.2%
Q3 2025$2.491.3B365.0M+7.9%+22.1%
Q2 2025$2.351.3B344.6M+10.3%+65.5%
Q1 2025$2.121.2B311.4M+11.1%+42.3%
Q4 2024$1.991.2B292.2M
Q3 2024$2.041.2B300.5M
Q2 2024$1.421.2B208.8M
Q1 2024$1.491.1B219.4M
ResMed (RMD) — Earnings